Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Adult hypophosphatasia (HPP) symptoms often worsen gradually because low alkaline phosphatase activity from ALPL gene changes allows mineral-blocking substrates to build up, leading to progressive bone softening, recurring stress and pseudofractures, pyrophosphate arthropathy, muscle pain, fatigue, and early tooth loss. Progression can be accelerated by aging, inactivity, pregnancy, vitamin B6 disturbances, long delays in diagnosis, and certain bone drugs such as bisphosphonates or denosumab that may cause more harm than benefit in HPP. Doctor next steps usually include documenting persistently low serum ALP, testing vitamin B6 (PLP) and urine phosphoethanolamine, confirming with ALPL genetic testing, imaging poorly healing fractures, and referral to a metabolic bone specialist or endocrinologist for management options including enzyme replacement therapy. Because HPP is commonly mistaken for osteoporosis, fibromyalgia, or arthritis, the treatment path can look very different once it is correctly identified. There are several important factors to consider before your next appointment, so see below to understand more.
If your bone, joint, muscle, or dental symptoms keep escalating and no explanation has stuck, a fast, structured review of what you are experiencing can help you organize the details that matter most to a clinician, including patterns of pain,
Why Adult HPP Symptoms Worsen Over Time: Doctor Next Steps
Hypophosphatasia (HPP) is a rare metabolic bone disease caused by genetic mutations that reduce tissue-nonspecific alkaline phosphatase (TNSALP) activity. In adults, HPP symptoms often appear mild at first but can worsen over time. Understanding why this happens—and knowing what to do next—can help you and your doctor manage the condition more effectively.
What Are “hpp symptoms in adults”?
Adult HPP can manifest in a variety of ways. Common signs and symptoms include:
Many adults report a gradual increase in pain, more frequent fractures, or worsening muscle fatigue as they age. It’s not simply “wear and tear”—there are specific reasons the disease tends to progress.
Why HPP Symptoms in Adults Often Worsen
Progressive Enzyme Deficiency
• Genetic mutations in ALPL (the gene for TNSALP) are present at birth, but body demands change over time.
• As you age, bone remodeling and repair processes depend more on normal alkaline phosphatase activity. Insufficient enzyme levels gradually impair bone strength.
Accumulation of Toxic Substrates
• Low TNSALP leads to buildup of inorganic pyrophosphate (PPi) and pyridoxal 5′-phosphate (PLP).
• Elevated PPi inhibits bone mineralization, making bones more brittle. Over years, this can increase fracture risk.
• High PLP can contribute to neurological symptoms, including fatigue and mood changes.
Unrecognized Stress on Bones and Joints
• Mild HPP may not trigger severe problems until a minor injury or repetitive strain causes a stress fracture.
• Over time, repeated micro-injuries add up, leading to chronic pain and mobility issues.
Age-Related Changes in Bone Density
• Normal aging can reduce bone density. In adults with HPP, this effect compounds the already poor mineralization.
• Hormonal changes (menopause in women, testosterone decline in men) can accelerate bone loss.
Secondary Lifestyle and Health Factors
• Lack of weight-bearing exercise, vitamin D insufficiency, or poor nutrition can worsen bone health.
• Certain medications (like bisphosphonates) are contraindicated in HPP and may inadvertently make symptoms worse if misused.
Recognizing these factors helps explain why an adult with mild HPP in their 20s or 30s may face more severe pain, fractures, or mobility limits in later decades.
Doctor’s Next Steps: Diagnosing and Monitoring Adult HPP
Detailed Medical and Family History
– Document lifetime history of fractures, dental issues, and muscle/joint pain.
– Ask about family members with similar problems, early tooth loss, or unexplained limb pain.
Laboratory Testing
– Serum alkaline phosphatase (ALP): typically low in HPP.
– Vitamin B6 (pyridoxal 5′‐phosphate) levels: often elevated.
– Calcium, phosphate, parathyroid hormone to rule out other bone disorders.
Genetic Testing
– Confirm ALPL gene mutations.
– Helps predict disease severity, guide family counseling, and inform treatment.
Imaging Studies
– X-rays: identify stress fractures, pseudofractures, or bone demineralization.
– Dual-energy X-ray absorptiometry (DEXA): assess bone mineral density.
– MRI or CT for complex cases (e.g., suspected spinal involvement).
Specialist Referral
– Metabolic bone disease specialist or endocrinologist experienced in HPP.
– Orthopedist for fracture management.
– Dentist or oral surgeon for dental complications.
Treatment Options: Slowing Progression and Managing Symptoms
While adult HPP cannot be “cured,” several strategies can slow symptom progression and improve quality of life.
Enzyme Replacement Therapy (ERT)
• Asfotase alfa is a recombinant tissue-nonspecific alkaline phosphatase.
• Approved for pediatric-onset HPP, with growing evidence of benefit in adults.
• May improve bone mineralization, reduce fractures, and lessen pain over months.
Pain Management
• Acetaminophen or certain nonsteroidal anti-inflammatory drugs (NSAIDs) can help.
• Avoid long-term opioid use unless absolutely necessary.
• Consider topical analgesics or nerve‐targeted therapies for localized pain.
Physical Therapy and Exercise
• Low-impact, weight-bearing activities strengthen muscles and bones.
• Aquatic therapy reduces joint stress.
• Balance training helps prevent falls.
Nutrition and Supplements
• Ensure adequate calcium and vitamin D (under medical supervision).
• High‐protein diet to support bone and muscle health.
• Avoid oversupplementing phosphorus, which may worsen mineralization.
Dental Care
• Early evaluation by a dentist familiar with HPP.
• Routine cleanings, fluoride treatments, and good oral hygiene.
• Address loose or missing teeth with implants or bridges as needed.
Medication Cautions
• Bisphosphonates and denosumab are generally avoided—they inhibit bone remodeling further.
• Steroids can worsen bone density; use only when essential.
Monitoring and Follow-Up
Regular follow-up is key to catching new issues early:
When to Seek Immediate Medical Attention
Some HPP-related issues can be serious. If you experience any of the following, speak to a doctor promptly or go to the emergency department:
Free, Online Symptom Check
If you’re concerned about your symptoms or unsure whether they could be related to HPP or another condition, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather clues before your next medical visit. (https://ubiehealth.com/)
Speak to a Doctor
HPP can be a lifelong condition that evolves over time. While this overview covers key reasons why adult HPP symptoms worsen—and outlines diagnostic and management steps—it doesn’t replace personalized medical advice. Always speak to a doctor about any new, severe, or life-threatening symptoms. Regular medical follow-up and a coordinated care team are essential to staying on top of your health.
By understanding the drivers of worsening symptoms and taking proactive steps—through accurate diagnosis, targeted therapy, and lifestyle adjustments—you can preserve bone strength, reduce pain, and maintain an active life despite adult HPP.
(References)
* Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019 Feb;7(2):93-105. doi: 10.1016/S2213-8587(18)30307-3. Epub 2018 Dec 14. PMID: 30558909.
* Wang L, Main K, Wang H, Julien O, Dufour A. Biochemical Tools for Tracking Proteolysis. J Proteome Res. 2021 Dec 3;20(12):5264-5279. doi: 10.1021/acs.jproteome.1c00289. Epub 2021 Sep 7. PMID: 34491759.
* Wang Q, Feng K, Wan G, Liao W, Jin J, Wang P, Sun X, Wang W, Jiang Q. A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression. J Nanobiotechnology. 2025 Jan 16;23(1):18. doi: 10.1186/s12951-024-03046-7. Epub 2025 Jan 16. PMID: 39815302; PMCID: PMC11737235.
* Ramage IJ, Howatson AJ, Beattie TJ. Hypophosphatasia. J Clin Pathol. 1996 Aug;49(8):682-4. doi: 10.1136/jcp.49.8.682. PMID: 8881924; PMCID: PMC500617.
* Jetter EM, Lucke-Wold BP. When the diagnosis misses the mark: The psychiatric cost of misdiagnosing hypophosphatasia as fibromyalgia. World J Clin Cases. 2025 Nov 6;13(31):109020. doi: 10.12998/wjcc.v13.i31.109020. PMID: 41283183; PMCID: PMC12635855.
* Högler W, Linglart A, Petryk A, Kishnani PS, Seefried L, Fang S, Rockman-Greenberg C, Ozono K, Dahir K, Martos-Moreno GÁ. Growth and disease burden in children with hypophosphatasia. Endocr Connect. 2023 May 1;12(5):e220240. doi: 10.1530/EC-22-0240. Epub 2023 Apr 25. PMID: 36917043; PMCID: PMC10160547.
* Lei L, Cong R, Ni Y, Cui X, Wang X, Ren H, Wang Z, Liu M, Tu J, Jiang L. Dual-Functional Injectable Hydrogel for Osteoarthritis Treatments. Adv Healthc Mater. 2024 Feb;13(5):e2302551. doi: 10.1002/adhm.202302551. Epub 2023 Nov 30. PMID: 37988224.
* Thrailkill KM, Kalaitzoglou E, Fowlkes JL. Emerging therapies for the treatment of rare pediatric bone disorders. Front Pediatr. 2022;10:1012816. doi: 10.3389/fped.2022.1012816. Epub 2022 Oct 11. PMID: 36304528; PMCID: PMC9592743.
* Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR. Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int. 2019 Sep;30(9):1713-1722. doi: 10.1007/s00198-019-04921-y. Epub 2019 Mar 26. PMID: 30915507.
* Whyte MP, Leung E, Wilcox WR, Liese J, Argente J, Martos-Moreno GÁ, Reeves A, Fujita KP, Moseley S, Hofmann C, Study 011-10 Investigators. Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study. J Pediatr. 2019 Jun;209:116-124.e4. doi: 10.1016/j.jpeds.2019.01.049. Epub 2019 Apr 9. PMID: 30979546.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.